| 1LXL | A:1-27 | NMR STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH, MINIMIZED AVERAGE STRUCTURE |
| 1MAZ | A:1-27 | X-RAY STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH |
| 1R2D | A:1-27 | STRUCTURE OF HUMAN BCL-XL AT 1.95 ANGSTROMS |
| 1R2E | A:2-27 | HUMAN BCL-XL CONTAINING A GLU TO LEU MUTATION AT POSITION 92 |
| 1R2G | A:1-27 | HUMAN BCL-XL CONTAINING A PHE TO TRP MUTATION AT POSITION 97 |
| 1R2H | A:1-27 | HUMAN BCL-XL CONTAINING AN ALA TO LEU MUTATION AT POSITION 142 |
| 1R2I | A:1-27 | HUMAN BCL-XL CONTAINING A PHE TO LEU MUTATION AT POSITION 146 |
| 1YSG | A:5-31 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH "SAR BY NMR" LIGANDS |
| 1YSI | A:5-31 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND |
| 1YSN | A:5-31 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND |
| 2O1Y | A:5-31 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND |
| 2O2M | A:6-26 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND |
| 2O2N | A:6-26 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND |
| 2P1L | G:2-26; G:2-26; G:2-26; G:2-26 | STRUCTURE OF THE BCL-XL:BECLIN 1 COMPLEX |
| 2PON | B:57-83 | SOLUTION STRUCTURE OF THE BCL-XL/BECLIN-1 COMPLEX |
| 2YXJ | B:2-27; B:2-27 | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH ABT-737 |
| 3PL7 | B:4-27; B:4-27 | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH THE BAXBH3 DOMAIN |
| 3QKD | B:2-27; B:2-27 | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH A QUINAZOLINE SULFONAMIDE INHIBITOR |
| 3R85 | D:3-26; D:3-26; D:3-26; D:3-26 | CRYSTAL STRUCTURE OF HUMAN SOUL BH3 DOMAIN IN COMPLEX WITH BCL-XL |
| 1MK3 | A:5-31 | SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN |
| 1ZY3 | A:5-31 | STRUCTURAL MODEL OF COMPLEX OF BCL-W PROTEIN WITH BID BH3-PEPTIDE |
| 1YSW | A:5-31 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND |
| 2O21 | A:5-31 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND |
| 2O22 | A:5-31 | SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND |
| 2W3L | B:9-33; B:9-33 | CRYSTAL STRUCTURE OF CHIMAERIC BCL2-XL AND PHENYL TETRAHYDROISOQUINOLINE AMIDE COMPLEX |
| 2XA0 | B:10-31; B:10-31 | CRYSTAL STRUCTURE OF BCL-2 IN COMPLEX WITH A BAX BH3 PEPTIDE |
)
)